Allouche Cyril
Insider CIK 1744573 · RVNC Principal Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RVNC Revance Therapeutics, Inc. | S Sale | 2019-03-18 | 2019-03-19 | 498 | $15.48 | $7.7K | 6,400 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2019-03-15 | 2019-03-19 | 252 | $15.45 | $3.9K | 6,898 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2019-01-24 | 2019-01-25 | 6,500 | — | $0 | 6,500 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2019-01-24 | 2019-01-25 | 3,150 | — | $0 | 7,150 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2019-01-22 | 2019-01-23 | 625 | — | $0 | 6,875 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2019-01-22 | 2019-01-23 | 625 | $17.77 | $11.1K | 4,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2019-01-22 | 2019-01-23 | 625 | $13.35 | $8.3K | 4,625 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2019-01-03 | 2019-01-04 | 375 | $19.48 | $7.3K | 4,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | J Other | 2018-12-31 | 2019-01-02 | 375 | $17.11 | $6.4K | 4,375 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2018-11-20 | 2018-11-21 | 491 | $20.66 | $10.1K | 4,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2018-11-15 | 2018-11-16 | 259 | $20.99 | $5.4K | 4,491 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2018-11-09 | 2018-11-09 | 2,188 | — | $0 | 7,500 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2018-11-09 | 2018-11-09 | 2,188 | $13.35 | $29.2K | 6,938 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2018-11-09 | 2018-11-09 | 2,188 | $23.72 | $51.9K | 4,750 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2018-07-06 | 2018-07-06 | 393 | $28.35 | $11.1K | 4,750 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | J Other | 2018-06-29 | 2018-07-03 | 393 | $23.33 | $9.2K | 5,143 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2018-06-20 | 2018-06-22 | 9,500 | — | $0 | 9,500 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2018-06-20 | 2018-06-22 | 250 | — | $0 | 4,750 | SEC↗ |